phrykt

SS Innovations International, Inc. (SSII): who owns it and who trades it

As of Oct 30, 2026, SSII insiders reported 1 open-market sale worth $100K and 3 purchases worth $5.2M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Srivastava Sudhir (CEO), with $100K.

Latest filing Oct 30, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

In the last 12 months, SSII insiders reported $5.2M of open-market purchases and $100K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$5.2M
3 trades, 3 people
Sales, 12 months
$100K
1 trades, 1 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Sep 4, 2026
Filed Sep 9, 2026

Purchases and sales by month

$5.2M$5.2MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Sep 4, 2026Srivastava SudhirCEOSale33,333$3.00$100KForm 4
Mar 6, 2026Frederic H MollDirectorPurchase501,253$3.99$2MForm 4
Mar 6, 2026Timothy P. AdamsDirectorPurchase300,000$3.99$1.2MForm 4
Mar 6, 2026Srivastava SudhirCEOPurchase498,753$4.01$2MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Srivastava SudhirChairman and CEO, Director, 10% owner$2M$100KSep 4, 2026
Frederic H MollDirector, 10% owner$2M–Mar 6, 2026
Timothy P. AdamsDirector$1.2M–Mar 6, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

SSII short interest

Low short interest. Less than 0.1% of SSII shares are sold short. Over the last 12 reports the number of shares short went up 11%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 64,284 SSII shares were sold short, 0.0% of the shares outstanding, down 7.6% from the report before. At the average daily volume of 56,614 shares, buying them all back would take about 1.1 trading days (days to cover).

Shares short, % of all shares

0.03%May 15Oct 300.07%

Days to cover

1.1May 15Oct 302.2

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202664,2840.03%-8%56,6141.1
Oct 15, 202669,5910.03%+3%58,8271.2
Sep 30, 202667,7640.03%+14%79,5691.0
Sep 15, 202659,6610.03%-18%60,9951.0
Aug 31, 202673,1410.04%+8%38,2161.9
Aug 14, 202667,9250.03%-14%41,4041.6
Jul 31, 202679,0400.04%-40%89,9171.0
Jul 15, 2026131,0670.07%+179%65,0492.0
Jun 30, 202646,9180.02%-12%60,0401.0
Jun 15, 202653,1330.03%+3%78,3731.0
May 29, 202651,5780.03%-11%51,9981.0
May 15, 202658,0210.03%+18%48,6641.2

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

SS Innovations International company events

SS Innovations International filed 29 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership). The latest was on Oct 26, 2026.

  1. Oct 26, 2026AnnouncementSSi issued a press release announcing that the Company’s SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console were showcased in successful telesurgeries performed in October 2026 during the European Association for Cardio-Thoracic Surgery Annual Meeting in Barcelona, Spain and… Filing
  2. Oct 13, 2026AnnouncementSSi issued a press release announcing that, on October 5, 2026, the Company submitted its response to a request for additional information letter received from the United States Food and Drug Administration with respect to its 510(k) application for SSi’s SSi Mantra surgical robotic system. Filing
  3. Oct 13, 2026AgreementSSi entered into a Securities Purchase Agreement with an institutional investor, and consummated the transactions contemplated thereby. Filing
  4. Oct 5, 2026AnnouncementShared information with investors. Filing
  5. Sep 10, 2026AnnouncementSSi issued a press release which provided an update on the Company’s continuing progress and milestones. Filing
  6. Aug 26, 2026LeadershipSarah Romano is no longer serving as Chief Financial Officer of the Company. Filing
  7. Aug 13, 2026ResultsReleased financial results. Filing
  8. Jul 17, 2026AnnouncementSSi issued a press release announcing that the Company’s advanced SSi Mantra surgical robotic system will be showcased at the 2026 Society of Robotic Surgery Annual Meeting in Hollywood, Florida on July 23 - 26, 2026. Filing
  9. Jul 14, 2026LeadershipReported a change among its top officers or directors, or their pay. Filing
  10. Jul 7, 2026AnnouncementSSi issued a press release announcing that the Company’s subsidiary, the SS International Centre for Robotics Surgery, has graduated its first class in a specialized training course designed to provide surgeons and other healthcare professionals with classroom instruction and hands-on learning in… Filing
  11. Jun 30, 2026AnnouncementSSi issued a press release announcing the Company was named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards. Filing
  12. Jun 18, 2026AgreementThe Company entered into an ATM Sales Agreement with Virtu Americas LLC, to sell shares of its common stock, par value $0.0001 per share, for an aggregate offering price of up to $50 million from time to time, through an “at the market offering” program under which Virtu will act as an exclusive… Filing
  13. Jun 15, 2026AnnouncementShared information with investors. Filing
  14. Jun 4, 2026AnnouncementSSi issued a press release announcing that the world’s longest-distance robotic telesurgery was successfully performed on May 26, 2026, utilizing the Company’s SSi Mantra surgical robotic system, from Georgetown, Guayana to a patient in Indore, India, at a communication line distance of more than… Filing
  15. May 26, 2026LeadershipMilan Rao informed the Company that he would step down as Global Chief Operating Officer and Chief Financial Officer, effective May 25, 2026. Filing
  16. May 13, 2026ResultsReleased financial results. Filing
  17. May 7, 2026AnnouncementSSi issued a press release announcing the successful completion of a long-distance cross-border telesurgery utilizing the SSi Mantra surgical robotic system and the SSi MantrAsana tele-surgeon console and spanning more than 6,000 miles from the surgeon located at the Royal Australian College of… Filing
  18. May 5, 2026AnnouncementSSi issued a press release announcing that more than 10,500 cumulative surgeries have been successfully performed with the Company’s SSi Mantra surgical robotic system. Filing
  19. Apr 23, 2026AnnouncementShared information with investors. Filing
  20. Apr 7, 2026AnnouncementSSi issued a press release announcing it is hosting the Global Multi-Specialty Robotic Surgery Conference (SMRSC 2026), being held in New Delhi, India, from April 9 to 11, 2026. Filing
  21. Mar 30, 2026AnnouncementThe Company issued a press release announcing that it had received regulatory approval for the SSi Mantra surgical robotic system for multiple indications in Colombia, Oman, Sri Lanka and Kenya. Filing
  22. Mar 18, 2026AnnouncementThe Company issued a press release announcing that its SSi Mantra surgical robotic system has been approved for telesurgeries in Indonesia and the Philippines and updating the number of telesurgeries performed utilizing the SSi Mantra. Filing
  23. Mar 10, 2026ResultsReleased financial results. Filing
  24. Mar 9, 2026SharesSold new shares outside a public offering. Filing
  25. Jan 13, 2026ResultsReleased financial results. Filing
  26. Jan 8, 2026LeadershipReported a change among its top officers or directors, or their pay. Filing
  27. Jan 6, 2026AnnouncementThe Company issued a press release announcing that SSi had completed the development of five new 5-millimeter surgical instruments for clinical use across multiple specialties, including pediatric, cardiac, and head and neck surgery, among other procedures involving smaller anatomical structures. Filing
  28. Dec 16, 2025AnnouncementShared information with investors. Filing
  29. Dec 8, 2025AnnouncementThe Company issued a press release announcing that the Company submitted a 510(k) premarket notification to the United States Food and Drug Administration on December 5, 2025, for its SSi Mantra surgical robotic system for multiple specialty procedure types, including: general, urological… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

SS Innovations International financials

Questions about SS Innovations International, Inc. (SSII) stock

Are SSII insiders buying or selling?

In the last 12 months, SSII insiders reported 3 open-market purchases worth $5.2M and 1 sale worth $100K. The latest trade was on Sep 4, 2026. See every trade.

What is the short interest in SSII?

As of Oct 30, 2026, 64,284 SSII shares were sold short, 0.0% of the shares outstanding, down 7.6% from the report before. At the average daily volume of 56,614 shares, buying them all back would take about 1.1 trading days (days to cover). See the history.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.